Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Nanomedicine. 2012 Oct 3;9(3):419–427. doi: 10.1016/j.nano.2012.09.003

Figure 1.

Figure 1

Percent of loaded KAFAK released in 10% FBS PBS solution at 37°C. A) MBA cross-linked only nanoparticles. B) DMHA only or DMHA and MBA cross-linked nanoparticles. Lines represent data from two sample sets.